Danish Pharmacovigilance Update, 15 September 2011

In this issue of Danish Pharmacovigilance Update:

• Significant increase in off-label use of AeroBec® in children under the age of five
• Inquiry about article in Danish Pharmacovigilance Update from January 2011 on fluoroquinolones and risk of QT prolongation
• NSAIDs and possible risk of cardiac adverse reactions
• Warning against the product Melanotan (the Barbie drug)
• The Danish Medicines Agency wants to receive reports of suspected antibiotic resistance
• The Danish Medicines Agency focuses attention on consumption and safety of biological medicines for children and adolescents
• Danish Drug Interaction Database expanded with information about class effect, SAD products and product names for natural remedies and strong vitamins

Download the newsletter in the box to the right.